CRISPR-Cas-enabled nanocarriers in hepatocellular carcinoma: Emerging gene-editing strategies for precision liver therapy
Hepatocellular carcinoma (HCC) remains a highly deadly global malignancy with limited curative treatments, frequent recurrence, and delayed diagnosis. Gene editing systems using CRISPR-Cas offer great potential to correct cancer-causing mutations, reprogram the tumor microenvironment, and overcome d...
Shranjeno v:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
KeAi Communications Co., Ltd.
2026-04-01
|
| Serija: | Gastroenterology & Endoscopy |
| Teme: | |
| Online dostop: | http://www.sciencedirect.com/science/article/pii/S2949752326000105 |
| Oznake: |
Brez oznak, prvi označite!
|